The PubMed bibliographic record reports a study published in Science Advances (Sci Adv) on 18 September 2026 (Vol. 12, Issue 38) with DOI 10.1126/sciadv.aee5421 and PMID 42758812. The article title is “Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells.” The published record on PubMed provides authorship, affiliations, and standard citation metadata.
The explicit claim in the article title is that a secreted viral protein, ORF8, acts to reprogram macrophages in a manner that enhances infection of lung epithelial cells by SARS-CoV-2. This frames a biological axis in which a viral factor released from infected cells or virions influences innate immune cells, producing downstream effects on epithelial cell susceptibility to infection.
The author list includes Yusuke Matsui, Rahul K. Suryawanshi, Mauricio Montano, Taha Y. Taha, Mir M. Khalid, Limeng Sun, Kanika Khanna, Jin Tang, Yuan Zhou, Robyn M. Kaake, Xiaohui Fang, Mazharul Maishan, Michael A. Matthay, Nevan J. Krogan, Melanie Ott, and others. Affiliations span multiple institutions including the J. David Gladstone Institutes, Michael Hulton Center for HIV Cure Research at Gladstone, the Laboratory of Neurological Infections and Immunity (NIAID Rocky Mountain Laboratories), UCSF departments (Bioengineering and Therapeutic Sciences, Quantitative Biosciences Institute, Cardiovascular Research Institute, Department of Anesthesia, Department of Medicine), and Biohub. The multidisciplinary affiliations indicate contributions from virology, immunology, bioengineering, cardiovascular research, and clinical medicine.
From the wording in the title alone, the study asserts a sequence of interactions:
This phrasing implies cross-talk between infected or virus-exposed immune cells and epithelial targets in the lung microenvironment. The title identifies ORF8 and macrophages as central actors in a process that increases epithelial cell infection, but it does not provide mechanistic specifics (for example, receptor interactions, signaling pathways, cytokines, or whether this occurs in primary human tissue, cell lines, or animal models).
Based on the title and bibliographic information alone, the work highlights ORF8 as a viral factor potentially involved in modulating host innate immunity and altering tissue susceptibility to infection. If substantiated by the full study, this axis could be relevant to:
It should be emphasized that these implications are general and inferential, based solely on the title wording and not on the underlying data, methods, or conclusions presented in the full text.
The PubMed content supplied here contains citation metadata and the title but does not include the article abstract text, figures, methods, results, or conclusions. Absent from the provided source are:
Because these key elements are not present in the provided PubMed snippet, no additional experimental or outcome claims can be made beyond the title statement.
The PubMed entry provides the DOI (10.1126/sciadv.aee5421) and PMID (42758812) for locating the full article. To evaluate experimental design, reproducibility, and the strength of the evidence supporting the title claim, consult the full text in Science Advances via the DOI link, the journal website, or institutional access. The PubMed record lists the authors and affiliations for correspondence and author queries.
Note on scope of this summary
This rewrite preserves the factual content available in the supplied PubMed record. The title conveys the principal finding; however, the detailed experimental evidence, methods, and quantitative findings were not included in the source text provided and therefore are not reported here. For full appraisal, readers should retrieve and review the complete published article.